Drug Discovery News
-
Eisai, Biogen expand their agreement to codevelop and commercialize AD drug
Drug Discovery | News | 0 Comment | 24 Oct, 2017
Japan’s Eisai and US based Biogen announced the expansion of their existing collaboration agreement to develop and commercialise investigational therapies for Alzheimer&...Read more
-
Drug Discovery | Opinion | 0 Comment | 13 Oct, 2017
Q. Can you briefly explain this new blood testing technology and how is it different from the more conventional tests that path labs do? The cobas m 511 represents a new era of haematology...Read more
-
Novel bi-specific antibody shows strong therapeutic potential to treat Zika virus infection
Drug Discovery | News | 0 Comment | 12 Oct, 2017
Singapore - The Journal Cell published data with a bi-specific antibody against Zika virus infection. The article is entitled, “A Human Bi-specific Antibody against Zika Virus with Hi...Read more
-
Drug Discovery | News | 0 Comment | 10 Oct, 2017
Singapore – Johnson & Johnson (J&J) announced the launch of its three-monthly long-acting treatment for schizophrenia in Singapore. It is the first and only schizophrenia medi...Read more
-
Chiome Bioscience selects ProBioGen for GlymaxX antibody manufacturing program
Drug Discovery | News | 0 Comment | 05 Oct, 2017
ProBioGen AG, a premier service & technology provider for complex therapeutic glycoproteins and Chiome Bioscience Inc., a Japanese antibody discovery and development company, jointly an...Read more
-
Regulatory approval in Europe granted for Synthon's Glatiramer Acetate
Drug Discovery | News | 0 Comment | 05 Oct, 2017
Synthon announced that it has successfully concluded the decentralized procedures for glatiramer acetate 40 mg/ml pre-filled syringe for the treatment of relapsing forms of multiple scleros...Read more
-
Sato And Eisai Pharma co-promote antifungal agent in Japan
Drug Discovery | News | 0 Comment | 03 Oct, 2017
Sato Pharmaceutical Co. Ltd., Eisai Co. Ltd., and Seren Pharmaceuticals Inc. announced that Sato Pharma and Eisai will co-promote a new triazole class oral antifungal agent (developmen...Read more
-
Korea to inject 500 billion won into pharma sector; aims to launch 100 new drugs by 2026
Drug Discovery | News | 0 Comment | 30 Sep, 2017
In a bid to place Korea on the biotech global map, the Korean government announced plans to will inject 500 billion won (US$448 million) into the pharmaceutical sector over the ...Read more
-
Indivumed partners with cancer research specialist Helomics
Drug Discovery | News | 0 Comment | 22 Sep, 2017
Indivumed which has a large cancer biobank and Helomics Corporation (Helomics) has announced their collaboration to analyze human cancer biospecimens and annotated clinical data from consen...Read more
-
GSK receives FDA nod for its triple drug inhaler
Drug Discovery | News | 0 Comment | 21 Sep, 2017
Bringing in much needed relief for patients suffering from Chronic Obstructive Pulmonary Disorder (COPD), the US FDA has granted approval to GSK’s triple therapy inhaler Trelegy Ellip...Read more
-
Nacimbio signs agreement with MYLAN Laboratories
Drug Discovery | News | 0 Comment | 19 Sep, 2017
The National Immunobiological Company (Nacimbio) which is a part of Rostec State Corporation has signed an agreement with Mylan Laboratories limited on the transfer of technology for the pr...Read more
-
CSL Behring announces FDA approval of Privigen for the treatment of CIDP in adults
Drug Discovery | News | 0 Comment | 15 Sep, 2017
Global biotherapeutics leader CSL Behring announced that the U.S. Food and Drug Administration (FDA) has approved Privigen for the treatment of adults with chronic inflammatory demyeli...Read more
-
Bristol-Myers Squibb collaborates with ENHANZE technology
Drug Discovery | News | 0 Comment | 15 Sep, 2017
US based Bristol-Myers Squibb Company and Halozyme Therapeutics, Inc. has announced a global collaboration and license agreement to develop subcutaneously administered Bristol-Mye...Read more
-
Invicro acquires Imanova to Expand Global Imaging Capabilities
Drug Discovery | News | 0 Comment | 12 Sep, 2017
Combined business delivers world-leading imaging capabilities to drive improved decision-making from early drug discovery to late-phase clinical development and software for research and dr...Read more
-
Boehringer collaborates with Gubra to develop next generation obesity treatments
Drug Discovery | News | 0 Comment | 11 Sep, 2017
Germany based Boehringer Ingelheim has committed up to €250 million ($300 million) to work with Gubra on obesity treatments. As per the deal, Boehringer can access Gubra&rsq...Read more
-
Targeted therapy for acute myeloid leukemia
Drug Discovery | News | 0 Comment | 04 Sep, 2017
Singapore - The steady march of progress in new treatments for patients with acute myeloid leukemia (AML), one of the deadliest blood cancers which takes more than 10,000 lives in the U.S. ...Read more
-
Korean companies mull on using AI for drug discovery
Drug Discovery | News | 0 Comment | 01 Sep, 2017
In a bid to speed up drug discovery process and boost R&D efforts, Korea Pharmaceutical and Bio-pharma Manufacturers Association (KPBMA) has launched their first task force to jointly p...Read more
-
FDA approved revolutionary immunotherapy for blood cancer patients
Drug Discovery | News | 0 Comment | 01 Sep, 2017
Singapore – The U.S. Food and Drug Administration (FDA) announced the approval of a new, cutting-edge gene therapy that reprograms a patient's immune system to find and kill cancer ce...Read more
